FrancophonIA/ELRC3.0 huggingface dataset:
English: • Fulphila is given as an injection into the tissue just under the skin (subcutaneous injection).
Croatian: Fulphila se daje kao injekcija u tkivo odmah ispod kože (supkutana injekcija).
English: Always use this medicine exactly as your doctor has told you.
Croatian: Uvijek primijenite lijek Fulphila točno onako kako Vam je rekao liječnik.
English: • The medicine is cloudy or there are particles in it.
Croatian: • Ako lijek izgleda mutan ili su u njemu vidljive čestice.
English: The safety and efficacy of pegfilgrastim in children has not yet been established.
Croatian: Sigurnost i djelotvornost pegfilgrastima u djece nisu još ustanovljene.
English: Clean your skin by using an alcohol wipe.
Croatian: Očistite kožu koristeći maramicu natopljenu alkoholom.
English: Common cases of leukocytosis (White Blood Count [WBC] > 100 x 109/l) have been reported (see section 4.4).
Croatian: Prijavljeni su česti slučajevi leukocitoze (broj leukocita > 100 × 109/L) (vidjeti dio 4.4).
English: For instructions on handling of the medicinal product before administration, see section 6.6.
Croatian: Za uputu o rukovanju lijekom prije primjene vidjeti dio 6.6.
English: This medicinal product should not be used to increase the dose of cytotoxic chemotherapy beyond established dose regimens.
Croatian: Ovaj lijek se ne smije koristiti kako bi se povisila doza citotoksične kemoterapije iznad doza utvrđenih režima doziranja.
English: Each pre-filled syringe contains 30 mg sorbitol (E420).
Croatian: Jedna napunjena štrcaljka sadrži 30 mg sorbitola (E420).
English: Fulphila is a biosimilar medicinal product.
Croatian: Fulphila je biosličan lijek.
English: The most frequently reported adverse reactions were bone pain (very common [≥ 1/10]) and musculoskeletal pain (common [≥ 1/100 to < 1/10]).
Croatian: Najčešće prijavljene nuspojave bile su bol u kostima (vrlo često [≥ 1/10]) i mišićno-koštana bol (često [≥ 1/100 i < 1/10]).
English: Particular care should be taken to distinguish the diagnosis of blast transformation of chronic myeloid leukaemia from acute myeloid leukaemia.
Croatian: Osobitu pozornost treba obratiti na razlikovanje dijagnoze blastične transformacije u kroničnoj mijeloičnoj leukemiji od akutne mijeloične leukemije.
English: Accidental exposure to freezing temperatures for a single period of less than 24 hours does not adversely affect the stability of Fulphila.
Croatian: Slučajno jednokratno izlaganje temperaturama zamrzavanja u razdoblju kraćem od 24 sata ne utječe nepovoljno na stabilnost lijeka Fulphila.
English: How do you, or the person injecting you, use Fulphila pre-filled syringe?
Croatian: Kako ćete Vi ili osoba koja Vam daje injekciju koristiti Fulphila napunjenu štrcaljku?
English:  Do not touch the cleaned area of the skin.
Croatian: X Ne dirajte očišćeni dio kože.
English: Pegfilgrastim is not recommended during pregnancy and in women of childbearing potential not using contraception.
Croatian: Ne preporučuje se koristiti pegfilgrastim tijekom trudnoće niti u žena reproduktivne dobi koje ne koriste kontracepciju.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/18/1329/001 1 pre-filled syringe EU/1/18/1329/002 1 pre-filled syringe with needle guard
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/18/1329/001 1 napunjena štrcaljka EU/1/18/1329/002 1 napunjena štrcaljka sa štitnikom za iglu
English: 0.6 mL of solution.
Croatian: 0,6 ml
English: Important: read the package leaflet before handling the pre-filled syringe.
Croatian: Važno: Pročitajte uputu o lijeku prije rukovanja napunjenom štrcaljkom.
English: Fulphila may be exposed to room temperature (not above 30°C) for a maximum single period of up to 72 hours.
Croatian: Fulphila se može izložiti sobnoj temperaturi (ne višoj od 30 °C) tijekom jednokratnog razdoblja od najviše 72 sata.
English: StevensJohnson syndrome
Croatian: StevensJohnsonov sindrom
English: Therefore, physicians should use caution when prescribing pegfilgrastim in patients with sickle cell trait or sickle cell disease, should monitor appropriate clinical parameters and laboratory status and be attentive to the possible association of this medicinal product with splenic enlargement and vaso-occlusive crisis.
Croatian: Stoga liječnici trebaju s oprezom prepisivati pegfilgrastim u bolesnika s nasljednim obilježjem srpastih stanica ili s bolesti srpastih stanica, pažljivo pratiti odgovarajuće kliničke i laboratorijske parametre te paziti na moguću povezanost ovog lijeka s povećanjem slezene i vazookluzivnom krizom.
English: • The used syringe should be disposed of in accordance with local requirements.
Croatian: • Iskorištene štrcaljke potrebno je zbrinuti sukladno nacionalnim propisima.
English: If you have forgotten a dose of Fulphila, you should contact your doctor to discuss when you should inject the next dose.
Croatian: Ako ste si zaboravili dati svoju dozu lijeka Fulphila, upitajte liječnika kada biste trebali injicirati sljedeću dozu.
English: If you develop or are likely to develop cancers of the blood, you should not use Fulphila, unless instructed by your doctor.
Croatian: Ukoliko imate ili postoji neposredna opasnost od razvoja oblika raka krvi, ne biste trebali primjenjivati lijek Fulphila, osim u slučaju da je to savjet Vašeg liječnika.
English: No dose change is recommended in patients with renal impairment, including those with end stage renal disease.
Croatian: Ne preporučuje se promjena doze u bolesnika s oštećenom bubrežnom funkcijom, uključujući i one s terminalnim stadijem bolesti bubrega.
English: Such elevation in white blood cells is transient, typically seen 24 to 48 hours after administration and is consistent with the pharmacodynamic effects of this medicinal product.
Croatian: Takav je porast broja leukocita prolazan, tipično se uočava od 24 do 48 sati nakon primjene lijeka i u skladu je s farmakodinamičkim učincima ovog lijeka.
English: This is known as a subcutaneous injection.
Croatian: To se naziva potkožnom (supkutanom) injekcijom.
English: Remove the pre-filled syringe tray from the package and gather the supplies needed for your injection: alcohol wipes, a cotton ball or gauze pad, a plaster and a sharps disposal container (not included).
Croatian: Izvadite podložak napunjene štrcaljke iz pakiranja i prikupite pribor potreban za davanje injekcije: alkoholne maramice, jastučić od vate ili gaze, flaster i spremnik za odlaganje oštrih predmeta (nije uključeno).
English: White blood cell (WBC) counts of 100 x 109/L or greater have been observed in less than 1 % of patients receiving pegfilgrastim.
Croatian: Broj leukocita od 100 × 109/L ili više primijećen je u manje od 1% bolesnika koji su primali pegfilgrastim.
English: After releasing the plunger, the pre-filled syringe safety guard will safely cover the injection needle.
Croatian: Nakon što ste oslobodili klip, sigurnosni štitnik štrcaljke prekrit će iglu za injekciju.
English: If leukocyte counts exceed 50 x 109/l after the expected nadir, this medicinal product should be discontinued immediately.
Croatian: Ako broj leukocita nakon očekivane najniže vrijednosti prelazi 50 × 109l, liječenje ovim lijekom treba odmah prekinuti.
English: Fulphila contains sorbitol and sodium acetate
Croatian: Fulphila sadrži sorbitol i natrijev acetat
English: Do not use this medicine after the expiry date which is stated on the carton, on the blister and on the syringe label after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji, na blisteru i naljepnici štrcaljke iza oznake „EXP“.
English: What should I do before I give myself a subcutaneous injection of Fulphila?
Croatian: Što trebam učiniti prije samoprimjene potkožne injekcije Fulphila?
English: Check the expiry date on the pre-filled syringe label (EXP).
Croatian: Provjerite rok valjanosti na naljepnici napunjene štrcaljke (iza oznake „EXP“).
English: See section 2 “Fulphila contains sorbitol and sodium”.
Croatian: Pogledajte dio 2, „Fulphila sadrži sorbitol i natrij“.
English: The injections should be given into the thigh, abdomen or upper arm.
Croatian: Injekcije je potrebno primijeniti u bedro, abdomen ili nadlakticu.
English: If you forget to inject Fulphila
Croatian: Ako ste zaboravili injicirati lijek Fulphila
English: Use a new pre-filled syringe and call your doctor or healthcare provider.
Croatian: Upotrijebite novu napunjenu štrcaljku i pozovite svog liječnika ili zdravstvenog radnika.
English: You may take Fulphila out of the refrigerator and keep it at room temperature (not above 30°C) for no longer than 3 days.
Croatian: Lijek Fulphila možete izvaditi iz hladnjaka i čuvati ga na sobnoj temperaturi (ne višoj od 30 °C), ali ne dulje od 3 dana.
English: - Stevens-Johnson syndrome, which can appear as reddish target-like or circular patches often with central blisters on the trunk, skin peeling, ulcers of mouth, throat, nose, genitals and eyes and can be preceded by fever and flu-like symptoms.
Croatian: - Stevens-Johnsonov sindrom, koji se može pojaviti kao crvenkaste mrlje u obliku mete ili kružne mrlje često sa središnjim mjehurićima na trupu, ljuštenje kože, vrijedovi u ustima, grlu, nosu, na genitalijama i očima, čemu može prethoditi vrućica i simptomi nalik gripi.
English: Pegfilgrastim is a protein produced by biotechnology in bacteria called E. coli.
Croatian: Pegfilgrastim je bjelančevina dobivena biotehnološkim postupkom u bakteriji E. coli.
English: - serious allergic reactions, including anaphylaxis (weakness, drop in blood pressure, difficulty breathing, swelling of the face).
Croatian: - ozbiljne alergijske reakcije, uključujući anafilaksiju (slabost, pad krvnog tlaka, otežano disanje,
English: Inspect the medicine and pre-filled syringe.
Croatian: Provjerite lijek i napunjenu štrcaljku
English: In an open label, single dose study (n = 31) various stages of renal impairment, including end-stage renal disease, had no impact on the pharmacokinetics of pegfilgrastim.
Croatian: U otvorenom ispitivanju pojedinačne doze (n=31) različiti stadiji oštećenja funkcije bubrega, uključujući terminalni stadij bolesti, nisu utjecali na farmakokinetiku pegfilgrastima.
English: To give yourself a subcutaneous injection you will need: - a pre-filled syringe of Fulphila; and - alcohol wipes or similar.
Croatian: Potrebni pribor Za samoprimjenu potkožne injekcije trebate: - napunjenu štrcaljku lijeka Fulphila; i - maramicu natopljenu alkoholom ili slično.
English: The safety and efficacy of pegfilgrastim administration in de novo AML patients aged < 55 years with cytogenetics t(15;17) have not been established.
Croatian: Sigurnost i djelotvornost primjene pegfilgrastima u bolesnika s de novo AML mlađih od 55 godina s citogenetskim nalazom t(15;17) nisu utvrđene.
English: Your doctor has given you Fulphila to encourage your bone marrow (part of the bone which makes blood cells) to produce more white blood cells that help your body fight infection.
Croatian: Liječnik Vam je propisao lijek Fulphila za poticanje funkcije koštane srži (dio kosti koji stvara krvne stanice) kako bi stvorila više bijelih krvnih stanica za borbu tijela protiv infekcija.
English:  Do not leave the pre-filled syringe exposed to direct sunlight.
Croatian:  Ne izlažite napunjenu štrcaljku izravnoj sunčevoj svjetlosti.
English: Pegfilgrastim did not affect reproductive performance or fertility in male or female rats at cumulative weekly doses approximately 6 to 9 times higher than the recommended human dose (based on body surface area) (see section 5.3).
Croatian: Pegfilgastrim nije utjecao na sposobnost reprodukcije ili plodnost mužjaka i ženki štakora nakon što su dobivali tjedne kumulativne doze, otprilike 6 do 9 puta više od doza preporučenih za ljude (procjena temeljem površine tijela) (vidjeti dio 5.3).
English: Severe skin reactions (Stevens-Johnson syndrome) have been reported with the use of pegfilgrastim.
Croatian: Prijavljene su teške kožne reakcije (Stevens-Johnsonov sindrom) povezane s primjenom pegfilgastima.
English: Important: handle syringe as pictured
Croatian: Važno: rukujte štrcaljkom kao što je prikazano
English: - Sweet's syndrome (plum-coloured, raised, painful lesions on the limbs and sometimes the face and neck with fever) has occurred but other factors may play a role.
Croatian: - Sweetov sindrom (ljubičaste, izdignute, bolne promjene na udovima, i ponekad i na licu i na vratu, praćene vrućicom) se pojavljivao, no i drugi faktori u tome mogu imati ulogu.
English: Warnings and precautions Talk to your doctor, pharmacist or nurse before using Fulphila: - if you experience an allergic reaction including weakness, drop in blood pressure, difficulty breathing, swelling of the face (anaphylaxis), redness and flushing, skin rash and areas of the skin that itch.
Croatian: Upozorenja i mjere opreza Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije primjene lijeka Fulphila: - ako imate alergijsku reakciju koja uključuje slabost, pad krvnog tlaka, otežano disanje, oticanje lica (anafilaksa), crvenilo i navale crvenila, osip na koži ili područja kože koja svrbe; - ako počnete kašljati, imate vrućicu ili otežano disanje.
English: Cutaneous vasculitis1,2
Croatian: Kožni vaskulitis1,2
English: Elevations in lactate dehydrogenase and alkaline phosphatase1; Transient elevations in LFT's for ALT or AST1
Croatian: Povišena razina laktatdehidrogenaze i alkalne fosfataze1; Prolazno povišenje vrijednosti testova jetrene funkcije za ALT ili AST1
English: For a more comfortable injection, leave the pre-filled syringe at room temperature for about 30 minutes before injecting.
Croatian: Za ugodniju primjenu, ostavite napunjenu štrcaljku na sobnoj temperaturi oko 30 minuta prije injiciranja.
English: Very common side effects (may affect more than 1 in 10 people) - bone pain.
Croatian: Vrlo česte nuspojave (mogu se javiti u više od 1 na 10 osoba) - bol u kostima.
English: Uncommon (≥ 1/1,000 to < 1/100)
Croatian: (≥ 1/1000 do do < 1/1000) (< 1/10.000)
English: It is important that you do not try to give yourself the injection unless you have received training from your doctor, nurse or pharmacist.
Croatian: Važno je da ne pokušavate sami sebi dati injekciju ako niste prošli obuku kod svojeg liječnika, medicinske sestre ili ljekarnika.
English: • Belly, except for a 5 cm (2-inch) area right around your belly button.
Croatian: • Trbuh, osim u području unutar 5 cm od pupka.
English: Sodium acetate, sorbitol (E420), polysorbate 20, water for injections.
Croatian: Natrijev acetat, sorbitol (E420), polisorbat 20, voda za injekcije.
English: Open the tray, peeling away the cover.
Croatian: Otvorite podložak odvajanjem pokrova.
English: Do not use any Fulphila that is left in the syringe.
Croatian: Ne koristite lijek Fulphila koji je ostao u štrcaljki.
English: Medicines should be disposed of in accordance with local requirements.
Croatian: Lijekove treba zbrinuti sukladno nacionalnim propisima.
English: The onset of pulmonary signs such as cough, fever, and dyspnoea in association with radiological signs of pulmonary infiltrates, and deterioration in pulmonary function along with increased neutrophil count may be preliminary signs of Acute Respiratory Distress Syndrome (ARDS).
Croatian: Pojava plućnih simptoma, kao što su kašalj, vrućica i dispneja, povezanih s radiološkim znacima plućnih infiltrata i pogoršanjem funkcije pluća uz povišen broj neutrofila mogu biti prethodni znaci akutnog respiratornog distres sindroma (engl. acute respiratory distress syndrome, ARDS).
English: 6.6 Special precautions for disposal and other handling Before administration, Fulphila solution should be inspected visually for particulate matter.
Croatian: 6.6 Posebne mjere za zbrinjavanje i druga rukovanja lijekom Prije primjene potrebno je provjeriti sadrži li otopina lijeka Fulphila vidljive čestice.
English: The safety and efficacy of pegfilgrastim for the mobilisation of blood progenitor cells in patients or healthy donors has not been adequately evaluated.
Croatian: Sigurnost i djelotvornost pegfilgrastima u mobilizaciji krvotvornih matičnih stanica u bolesnika ili zdravih davatelja nije odgovarajuće ispitana.
English: Loss of response to Fulphila
Croatian: Gubitak odgovora na lijek Fulphila
English: Pre-filled syringe (Type I glass), with a fluorotec-coated bromobutyl rubber stopper and a stainless steel needle with or without an automatic needle guard.
Croatian: Napunjena štrcaljka (staklo tipa I), s čepom od bromobutilne gume obloženim fluorotec slojem i iglom od nehrđajućeg čelika, sa ili bez automatskog štitnika za iglu.
English: Healthcare professionals only The trade name of the administered product should be clearly recorded in the patient file.
Croatian: Samo za zdravstvene radnike Zaštićeni naziv primijenjenog lijeka mora se jasno navesti u bolesnikovoj medicinskoj dokumentaciji.
English: Hypersensitivity-type reactions, including skin rash, urticaria, angioedema, dyspnoea, erythema, flushing, and hypotension occurred on initial or subsequent treatment with pegfilgrastim (uncommon [≥ 1/1,000 to < 1/100]).
Croatian: Reakcije preosjetljivosti, uključujući osip na koži, urtikariju, angioedem, dispneju, eritem, navale crvenila i hipotenziju, javljale su se tijekom prvog ili sljedećeg liječenja pegfilgrastimom (manje često [≥ 1/1000 i < 1/100]).
English: There were no adverse effects observed in offspring from pregnant rats given pegfilgrastim subcutaneously, but in rabbits pegfilgrastim has been shown to cause embryo/foetal toxicity (embryo loss) at cumulative doses approximately 4 times the recommended human dose, which were not seen when pregnant rabbits were exposed to the recommended human dose.
Croatian: U potomstvu skotnih ženki štakora kojima je supkutano primijenjen pegfilgrastim nisu primijećene nuspojave, ali se pokazalo da je pegfilgrastim u zečeva uzrokovao embrionalnu/fetalnu toksičnost (gubitak embrija) pri kumulativnim dozama koje su bile oko 4 puta veće od preporučene doze za ljude, no isto se nije pookazalo kod primjene doza koje odgovaraju preporučenoj dozi za ljude.
English: Glomerulonephritis2
Croatian: Glomerulonefritis2
English: Turn the plunger to move the label into a position where you can remove the syringe label.
Croatian: Okrenite klip u položaj da možete odlijepiti naljepnicu sa štrcaljke.
English: • It is important that you do not try to give yourself the injection unless you have received training from your doctor or healthcare provider.
Croatian: Važno je da ne pokušavate dati sebi injekciju ako niste prošli obuku kod svojeg liječnika ili zdravstvenog radnika.
English: Uncommon side effects (may affect up to 1 in 100 people) - allergic-type reactions, including redness and flushing, skin rash, and raised areas of the skin that itch.
Croatian: Manje česte nuspojave (mogu se javiti u manje od 1 na 100 osoba) - reakcije alergijskog tipa, uključujući crvenilo i navale crvenila, osip na koži, izdignuta područja kože koja svrbe.
English: • The expiry date printed on the label has passed the last day of the month shown.
Croatian: • Ako je rok valjanosti otisnut na naljepnici istekao, odnosno ako je prošao posljednji dan navedenog mjeseca.
English: These could be symptoms of condition called “Capillary Leak Syndrome” which causes blood to leak from the small blood vessels into your body.
Croatian: Ovo mogu biti znakovi stanja koje se zove „sindrom povećane propusnosti kapilara“ koji uzrokuje izlaženje krvi iz malih krvnih žila unutar tijela.
English: Fulphila contains sorbitol and sodium acetate This medicine contains 30 mg sorbitol in each pre-filed syringe which is equivalent to 50 mg / mL.
Croatian: Fulphila sadrži sorbitol i natrijev acetat Ovaj lijek sadrži 30 mg sorbitola u jednoj napunjenoj štrcaljki što odgovara 50 mg/ml.
English: Uncommonly, cases have resulted in respiratory failure or Acute Respiratory Distress Syndrome (ARDS), which may be fatal (see section 4.4).
Croatian: Manje često su ovi slučajevi rezultirali respiratornim zatajenjem ili akutnim respiratornim distres sindromom (ARDS), koji mogu imati smrtni ishod (vidjeti dio 4.4).
English: Musculoskeletal pain (myalgia, arthralgia, pain in extremity, back pain, musculo-skeletal pain, neck pain)
Croatian: Mišićno-koštana bol (mijalgija, artralgija, bol u udovima, bol u leđima, mišićnokoštana bol, bol u vratu)
English: The safety and efficacy of pegfilgrastim have not been investigated in patients with myelodysplastic syndrome, chronic myelogenous leukaemia, and in patients with secondary Acute Myeloid Leukaemia (AML); therefore, it should not be used in such patients.
Croatian: Sigurnost i djelotvornost pegfilgrastima nisu ispitivane u bolesnika s mijelodisplastičnim sindromom, kroničnom mijeloičnom leukemijom te u bolesnika sa sekundarnom akutnom mijeloičnom leukemijom (AML), stoga se lijek ne smije primjenjivati u tih bolesnika.
English: G-CSF can promote growth of myeloid cells, including malignant cells, in vitro and similar effects may be seen on some non-myeloid cells in vitro.
Croatian: G-CSF može potaknuti rast mijeloidnih stanica, uključujući zloćudne stanice, in vitro a slični učinci mogu se primijetiti i na nekim nemijeloičnim stanicama in vitro.
English: For further instructions on how to inject yourself with pegfilgrastim, please read the instructions for use at the end of this leaflet.
Croatian: Dodatne upute o tome kako samostalno injicirati pegfilgrastim potražite u dijelu na kraju ove upute o lijeku.
English:  Do not use the pre-filled syringe if:
Croatian: Ne upotrebljavajte napunjenu štrcaljku:
English: Fulphila is used to reduce the duration of neutropenia (low white blood cell count) and the occurrence of febrile neutropenia (low white blood cell count with a fever) which can be caused by the use of cytotoxic chemotherapy (medicines that destroy rapidly growing cells).
Croatian: Fulphila se primjenjuje za smanjenje trajanja neutropenije (smanjenog broja bijelih krvnih stanica) i pojave febrilne neutropenije (smanjeni broj bijelih krvnih stanica praćen vrućicom), koji se mogu javiti uslijed primjene citotoksične kemoterapije (lijekova koji uništavaju brzorastuće stanice).
English: Pack size of one pre-filled syringe, in blistered packaging.
Croatian: Veličina pakiranja: jedna napunjena štrcaljka u blister pakiranju.
English: Grounds for the variation to the terms of the marketing authorisation(s) On the basis of the scientific conclusions for pegfilgrastim the CHMP is of the opinion that the benefit-risk balance of the medicinal product(s) containing pegfilgrastim is unchanged subject to the proposed changes to the product information.
Croatian: Na temelju znanstvenih zaključaka za pegfilgrastim, CHMP smatra da je omjer koristi i rizika lijeka(ova) koji sadrži(e) pegfilgrastim nepromijenjen, uz predložene izmjene informacija o lijeku.
English: INFORMATION IN BRAILLE Fulphila
Croatian: 16. PODACI NA BRAILLEOVOM PISMU fulphila
English: Driving and using machines Fulphila has no or negligible effect on the ability to drive or use machines.
Croatian: Upravljanje vozilima i strojevima Fulphila ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: India
Croatian: Indija
English: Splenic rupture2
Croatian: Splenomegalija2; Ruptura slezene2
English: Nausea1
Croatian: Mučnina1
English: For more information, see section 5.1 Excipient with known effect
Croatian: Za više informacija vidjeti dio 5.1
English: The recommended dose is one 6 mg subcutaneous injection (injection under your skin) using a pre-filled syringe and it should be given at least 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle.
Croatian: Uobičajena doza je 6 mg primijenjena jednom supkutanom injekcijom (injekcija pod kožu) pomoću napunjene štrcaljke, koja se mora dati najmanje 24 sata nakon posljednje doze kemoterapije na kraju svakog kemoterapijskog ciklusa.
English: The overall rate of febrile neutropenia was 9 % of patients treated with pegfilgrastim and 18 % of patients treated with filgrastim (difference 9 %, 95 % CI of -16.8 %,-1.1 %).
Croatian: Ukupna stopa febrilne neutropenije u bolesnika liječenih pegfilgrastimom iznosila je 9%, a 18% u bolesnika liječenih filgrastimom (razlika 9%, 95% CI od -16,8%, -1,1%).
English: Then LIFT the syringe off skin.
Croatian: Zatim ODIGNITE štrcaljku od kože.